Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation
Objective: To determine the clinical profile and blood pressure (BP) control rates of anticoagulated patients with hypertension and atrial fibrillation (AF). Methods: The PAULA study was a multicenter cross-sectional/retrospective observational study conducted throughout Spain. The study included pa...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2017-09-01
|
| Series: | Blood Pressure |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/08037051.2017.1313094 |
| _version_ | 1797685115155906560 |
|---|---|
| author | Vivencio Barrios Carlos Escobar Luis Prieto Valiente Jose María Lobos Diego Vargas-Ortega Jose Polo Nuria Marin Montañés |
| author_facet | Vivencio Barrios Carlos Escobar Luis Prieto Valiente Jose María Lobos Diego Vargas-Ortega Jose Polo Nuria Marin Montañés |
| author_sort | Vivencio Barrios |
| collection | DOAJ |
| description | Objective: To determine the clinical profile and blood pressure (BP) control rates of anticoagulated patients with hypertension and atrial fibrillation (AF). Methods: The PAULA study was a multicenter cross-sectional/retrospective observational study conducted throughout Spain. The study included patients with nonvalvular AF who were receiving vitamin K antagonist therapy during the past year and were attended at primary care setting. Adequate BP control was defined according to 2013 ESC/ESH guidelines. Results: A total of 1,222 hypertensive patients were included (mean age 77.9 ± 8.3 years; 51.2% women; CHADS2 2.5 ± 1.1; CHA2DS2-VASc 4.2 ± 1.4; HAS-BLED 1.6 ± 0.9). 33.5% of patients had diabetes, 24.9% heart failure and 14.0% prior stroke/transient ischemic attack. Mean BP was 131.4 ± 14.5/74.9 ± 9.8 mm Hg. With regard to antihypertensive treatment, most of patients were on combined therapy (67.9%). The commonest prescribed antihypertensive drugs were diuretics (64.4%), followed by angiotensin receptor blockers (30.1%), and beta blockers (29.4%). 75.2% of hypertensive patients achieved BP control targets; 86.6% of patients ≥80 years and 67.6% of diabetics. Conclusions: More than 75% of hypertensive patients with AF achieved BP goals, and this rate was higher in elderly. More than 2 thirds of patients were on combined therapy. BP control appears to be better in AF patients than in general hypertensive population. |
| first_indexed | 2024-03-12T00:40:48Z |
| format | Article |
| id | doaj.art-f5becf15f4f94e0c8d51068112cc8bb2 |
| institution | Directory Open Access Journal |
| issn | 0803-7051 1651-1999 |
| language | English |
| last_indexed | 2024-03-12T00:40:48Z |
| publishDate | 2017-09-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Blood Pressure |
| spelling | doaj.art-f5becf15f4f94e0c8d51068112cc8bb22023-09-15T08:45:21ZengTaylor & Francis GroupBlood Pressure0803-70511651-19992017-09-0126527928310.1080/08037051.2017.13130941313094Blood pressure control in anticoagulated patients with hypertension and atrial fibrillationVivencio Barrios0Carlos Escobar1Luis Prieto Valiente2Jose María Lobos3Diego Vargas-Ortega4Jose Polo5Nuria Marin Montañés6University Hospital Ramon y CajalUniversity Hospital La PazUniversidad Católica San Antonio de MurciaEast Area Primary CareHospital el Toyo, Hospital de Poniente El EjidoPrimary Care Health Center Casar de CáceresBayer HispaniaObjective: To determine the clinical profile and blood pressure (BP) control rates of anticoagulated patients with hypertension and atrial fibrillation (AF). Methods: The PAULA study was a multicenter cross-sectional/retrospective observational study conducted throughout Spain. The study included patients with nonvalvular AF who were receiving vitamin K antagonist therapy during the past year and were attended at primary care setting. Adequate BP control was defined according to 2013 ESC/ESH guidelines. Results: A total of 1,222 hypertensive patients were included (mean age 77.9 ± 8.3 years; 51.2% women; CHADS2 2.5 ± 1.1; CHA2DS2-VASc 4.2 ± 1.4; HAS-BLED 1.6 ± 0.9). 33.5% of patients had diabetes, 24.9% heart failure and 14.0% prior stroke/transient ischemic attack. Mean BP was 131.4 ± 14.5/74.9 ± 9.8 mm Hg. With regard to antihypertensive treatment, most of patients were on combined therapy (67.9%). The commonest prescribed antihypertensive drugs were diuretics (64.4%), followed by angiotensin receptor blockers (30.1%), and beta blockers (29.4%). 75.2% of hypertensive patients achieved BP control targets; 86.6% of patients ≥80 years and 67.6% of diabetics. Conclusions: More than 75% of hypertensive patients with AF achieved BP goals, and this rate was higher in elderly. More than 2 thirds of patients were on combined therapy. BP control appears to be better in AF patients than in general hypertensive population.http://dx.doi.org/10.1080/08037051.2017.1313094anticoagulationatrial fibrillationblood pressure controlhypertension |
| spellingShingle | Vivencio Barrios Carlos Escobar Luis Prieto Valiente Jose María Lobos Diego Vargas-Ortega Jose Polo Nuria Marin Montañés Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation Blood Pressure anticoagulation atrial fibrillation blood pressure control hypertension |
| title | Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation |
| title_full | Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation |
| title_fullStr | Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation |
| title_full_unstemmed | Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation |
| title_short | Blood pressure control in anticoagulated patients with hypertension and atrial fibrillation |
| title_sort | blood pressure control in anticoagulated patients with hypertension and atrial fibrillation |
| topic | anticoagulation atrial fibrillation blood pressure control hypertension |
| url | http://dx.doi.org/10.1080/08037051.2017.1313094 |
| work_keys_str_mv | AT vivenciobarrios bloodpressurecontrolinanticoagulatedpatientswithhypertensionandatrialfibrillation AT carlosescobar bloodpressurecontrolinanticoagulatedpatientswithhypertensionandatrialfibrillation AT luisprietovaliente bloodpressurecontrolinanticoagulatedpatientswithhypertensionandatrialfibrillation AT josemarialobos bloodpressurecontrolinanticoagulatedpatientswithhypertensionandatrialfibrillation AT diegovargasortega bloodpressurecontrolinanticoagulatedpatientswithhypertensionandatrialfibrillation AT josepolo bloodpressurecontrolinanticoagulatedpatientswithhypertensionandatrialfibrillation AT nuriamarinmontanes bloodpressurecontrolinanticoagulatedpatientswithhypertensionandatrialfibrillation |